MGMarc M. Greenberg

Marc M. Greenberg

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marc M. Greenberg has a total of 225 co-authors. Here are the top co-authors by number of shared publications:

  • Chuanzheng Zhou

    State Key Laboratory of Elemento-Organic Chemistry, Frontiers Science Center for New Organic Matter, Department of Chemical Biology, College of Chemistry, Nankai University, Tianjin 300071, China

    11 shared publications
  • Haozhe Yang

    Department of Chemistry, Johns Hopkins University, Baltimore, Maryland 21218, United States

    9 shared publications
  • Jonathan T. Sczepanski

    Department of Chemistry, Texas A&M University, College Station, Texas, USA

    8 shared publications
  • Shijun Gao

    Johns Hopkins University Department of Chemistry Baltimore , MD 21218

    8 shared publications
  • Jaeseung Kim

    Department of Chemistry, Johns Hopkins University, 3400 N. Charles St., Baltimore, Maryland 21218, and Department of Biological Sciences and Chemistry, Hedco Molecular Biology Laboratories, University of Southern California, Los Angeles, California 90089-1340

    7 shared publications
  • Kun Yang

    Department of Chemistry , Johns Hopkins University , 3400 N. Charles Street , Baltimore , Maryland 21218 , United States

    7 shared publications

Latest Publications

  • A Latent DNA–Protein Cross-Link Agent as a Chemical Adjuvant for Photodynamic Therapy

    by Xuanhe Jiang, Giulia Antoniali, Gianluca Tell, Marc M. Greenberg

    Photodynamic therapy (PDT) induces cell death in part through singlet oxygen (1O2)-mediated oxidation of DNA and other biomolecules. However, PDT effectiveness can be compromised in cancer cells by increased capacity for base excision repair (BER) of DNA lesions and/or proteostasis-associated tolerance of oxidative protein damage. We envisioned that using 1O2 to create DNA–protein cross-links (DPCs) would reduce the protective effect of BER overexpression and help overcome cellular PDT-resistance. Here, we describe a furan-containing adjuvant (MCF) that yields DPCs under PDT conditions. As a half-nitrogen mustard, MCF alkylates DNA and subsequently undergoes 1O2-mediated furan oxidation to generate a DNA-tethered 1,4-dicarbonyl electrophile that reacts with protein nucleophiles to form DPCs. MCF-dependent DPC formation was observed in nucleosome core particles and human cells under PDT conditions. DPC formation in NCPs and human cells increased in D2O, consistent with 1O2-mediated oxidation of MCF DNA adducts. DPC levels were also elevated in cells lacking functional SPRTN, a protease involved in DPC repair. Photochemical activation of MCF increased cellular toxicity. This effect was amplified by SPRTN truncation or proteasome inhibition, implicating proteolytic DPC processing in protection from MCF-induced phototoxicity. Importantly, MCF retained its cytotoxic enhancement in cells that overexpress the BER protein APE1. MCF also substantially reduced the detectable survival advantage of a HeLa cell population selected for resistance to PDT conditions. These results support MCF as a latent DPC precursor that potentiates PDT in cells with reduced sensitivity to oxidative photodamage.

  • Protein–Protein Cross-Linking by a DNA Damage-Derived Histone Modification

    by Zehui Zhou, Hanrui Yu, Marc M. Greenberg

    Nonenzymatic covalent modification (NECM) of lysine residues can be physiologically consequential. A NECM is formed by the oxidized abasic site (C4-AP), which is produced by DNA-damaging agents. C4-AP reacts with the ε-amine of histone lysines in nucleosome core particles (NCPs) to form an electrophilic 5-methylene pyrrolone NECM (KMP). KMP is also produced on histones in bleomycin-treated human cells. Here, we describe a molecule (1a) that yields KMP by reacting directly with histones in NCPs. KMP forms on lysines of all four core histones in the order H3 > H2A/H2B > H4. Biotinylated KMP-containing NCPs prepared using 1a were incubated with HeLa nuclear lysates in the presence of glutathione. NCP-protein cross-links were observed by native PAGE. Protein-protein cross-links (PPCs) were enriched through intact NCP pull-down and identified via tryptic digests by LC-MS/MS. Model reactions demonstrate KMP is more electrophilic than N-acyllysine post-translational modifications (PTMs) but does not form PPCs indiscriminately within NCPs. Enriched proteins are functionally biased, with overrepresentation of DNA binding, histone binding, histone PTMs, and transcription regulation. Proteins enriched by KMP-containing NCPs produced by generating C4-AP on DNA were analyzed in parallel. Similar overrepresented functions were observed when C4-AP was introduced near the H3/H4 N-tails, whereas a distinct group of proteins was enriched when C4-AP was introduced near the H2A acidic patch. PPC formation by KMP is modulated by the NCP environment. Combined with the known intracellular formation of KMP, this study inspires investigating whether PPC formation by this NECM impacts cell function and viability.

  • Mechanistic Studies on DNA Damage via Independent Generation of Purine Reactive Intermediates

    by Liwei Zheng, Marc M. Greenberg

    DNA oxidation is a collection of complex processes resulting from myriad reactive intermediates. That DNA is a heterogeneous polymer and is noncovalently bound to octameric protein complexes in the nuclei of mammalian cells, presents additional challenges when carrying out mechanistic studies. Experiments on nucleosides and oligonucleotides that employ photochemical precursors to reactive intermediates have provided valuable mechanistic insight into these biologically important chemical reactions. Experiments with these molecules have facilitated resolving mechanistic questions and uncovered new chemical pathways. In this review, studies in which independently generated purine nucleobase radicals are employed are summarized.

  • DNA–Protein Cross-Link Formation and Cellular Toxicity by Chimeric Bis-Electrophiles

    by Hanrui Yu, Xuanhe Jiang, Marc M. Greenberg

    DNA-protein cross-links (DPCs) and DNA-DNA interstrand cross-links (ICLs) strongly block genetic expression. Chemical agents that preferentially produce one of these DNA damage types over the other are potentially useful cellular probes and pharmacological agents but are uncommon. A chimeric alkylating agent (MEBAC) selectively forms DPCs over ICLs by reacting with the ε-amine of lysine. Here we determine that the majority of DPCs formed by MEBAC in NCPs are between dG and lysines in the histone amino terminal tails. We also compare the reactivity of MEBAC and an isomer (m-MEBAC). Model studies indicate that m-MEBAC reacts ∼50% more rapidly than MEBAC with a primary amine. DPC yields in nucleosome core particles (NCPs) from MEBAC and m-MEBAC are approximately equal at all but the highest concentration tested. Comparisons between the reactivity of MEBAC and a nitrogen mustard with NCPs and nuclear lysates illustrate the advantage of the former for generating DPCs. m-MEBAC and MEBAC cytotoxicity in human cells are comparable and are enhanced when proteasomal DPC repair is inhibited. These experiments validate the utility of this family of chimeric bis-electrophiles as chemical tools for forming DPCs in the test tube and in cells.


  • Noncompetitive Inhibition of DNA Polymerase β by a Nonnative Nucleotide

    by A. Hasan Howlader, Xuanhe Jiang, Zehui Zhou, Marc M. Greenberg

    Base excision repair (BER) is a DNA repair pathway responsible for protecting the genome against modified nucleotides. DNA polymerase β (Pol β) participates in this process by removing the remnants of a damaged nucleotide and filling in the resulting gap. Pol β is overexpressed in some cancers and is synthetic lethal in cells deficient in BRCA1/2, providing additional impetus for identifying inhibitors of this enzyme. We report noncovalent Pol β inhibitors that are nonnative nucleotides. The inhibitors were identified via a combination of structural and biochemical analysis, as well as serendipity, from an initial library of covalent inhibitor candidates in which diversity was introduced sequentially at the C3'- and C5-positions of pyrimidine nucleotides. The molecules are among the most potent Pol β inhibitors (Ki ≤ 70 nM) of the enzyme's polymerase and lyase activities. Kinetic analyses reveal that the molecules inhibit Pol β noncompetitively. Fluorescence anisotropy and kinetic experiments reveal that the more potent inhibitor binds in the lyase domain and does not prevent DNA binding. Neither the more potent noncompetitive inhibitor nor a neutral protide exhibits cytotoxic synergism with the DNA damaging agent methyl methanesulfonate in HeLa cells. Cell permeability experiments suggest that micromolar levels of the more potent noncompetitive inhibitor and corresponding protide are taken up by HeLa cells following 24 h incubation (25 μM). However, based upon a comparison with other molecules, it is possible that they are membrane bound. The molecules identified could be useful tools in biochemical studies and provide a starting point for creating new Pol β inhibitors that function in cells.

  • Examination of a Chimeric Bis-Electrophile for Selective DNA–Protein Cross-Linking and Mechlorethamine Reveals an Unknown Source of Nitrogen Mustard Cytotoxicity

    by Xuanhe Jiang, Son Vu, Hanrui Yu, Marc M. Greenberg

    DNA-protein cross-links (DPCs) are cytotoxic lesions whose study in cells is complicated by the lack of exogenous agents that produce them selectively over DNA-DNA interstrand cross-links (ICLs). The synthesis and reactivity of a chimeric bis-electrophile (MEBAC) that is comprised of a highly reactive alkylating agent and a lysine selective o-ethynyl benzaldehyde is described. DPC formation in nucleosome core particles (NCPs) by MEBAC is >40-times greater than that of ICLs. Cell viability experiments and the single cell Comet assay are consistent with NCP reactivity. Compared to a nitrogen mustard (mechlorethamine, MCE) MEBAC produces higher DPC yields and lower ICL yields in NCPs and in cells at comparable cytotoxicity. Cell viability experiments show that while DPCs from MEBAC are repaired by the metalloprotease SPRTN and the proteasome, only the former repairs such lesions produced by MCE. The inability of the proteasome to repair DPCs in MCE-treated cells likely contributes to the cytotoxicity of the nitrogen mustard. Proteomic analysis identifies several cysteine-rich E3 ligases involved in ubiquitination that are cross-linked to DNA in MCE-treated but not MEBAC-treated cells and suggests a chemical basis for why DPCs produced by the nitrogen mustard are not repaired by the proteasome. This investigation reveals a previously unknown source of nitrogen mustard cytotoxicity and indicates that MEBAC and molecules like it will be useful tools for studying DPCs in cells.


  • Open Access

    A human high-fidelity DNA polymerase holoenzyme has a wide range of lesion bypass activities

    by Rachel L Dannenberg, Joseph A Cardina, Helen Washington, Shijun Gao, Marc M Greenberg, Mark Hedglin

    During replication, lagging strand lesions are initially encountered by high-fidelity DNA polymerase (pol) holoenzymes comprised of pol δ and the PCNA sliding clamp. To proceed unhindered, pol δ holoenzymes must bypass lesions without stalling. This entails dNMP incorporation opposite the lesion (insertion) and the 5′ template deoxynucleotide (extension). Historically, it was viewed that high-fidelity pol holoenzymes stall upon encountering lesions, activating DNA damage tolerance pathways that are ultimately responsible for lesion bypass. Our recent study of four prominent lesions revealed that human pol δ holoenzymes support insertion and/or bypass for multiple lesions and the extent of these activities depends on the lesion and pol δ proofreading. In the present study, we expand these analyses to other prominent lesions. Collectively, analyses of 10 lesions from both studies reveal that the insertion and bypass efficiencies of pol δ holoenzymes each span a complete range (0%–100%). Consequently, the fates of pol δ holoenzymes upon encountering lesions are quite diverse. Furthermore, pol δ proofreading promoted holoenzyme progression at 7 of the 10 lesions and did not deter progression at any. Altogether, the results significantly alter our understanding of the replicative capacity of high-fidelity pol holoenzymes and their functional role(s) in lesion bypass.


  • Uridine Embedded within DNA is Repaired by Uracil DNA Glycosylase via a Mechanism Distinct from That of Ribonuclease H2

    by Chaochao Fan, Xuelin Zhan, Fengmin Guo, Qiang Li, Kuan Lu, Xiajing Shan, Yifei Zhou, Mengtian Ren, Marc M. Greenberg, Yijin Liu, et al.

    Uridine (rU) and 2'-deoxyuridine (dU) are common DNA lesions. dU is repaired through a base excision repair (BER) pathway initiated by uracil DNA glycosylase (UDG), while rU is typically removed from DNA via ribonucleotide excision repair, mediated by RNase H2. In this study, we report that rU is also repaired through the UDG-mediated BER pathway. We found that UDG catalyzes the removal of uracil from rU embedded in DNA, but exhibits no activity toward rU in RNA. Biochemical and crystallographic analyses revealed that the 2'-OH group of rU is effectively accommodated by UDG and directly participates in catalyzing the hydrolysis of the N-glycosidic bond. The abasic site product generated upon removal of uracil from rU by UDG is further processed by downstream BER enzymes to restore undamaged DNA. Our findings suggest that UDG-initiated BER constitutes a previously unrecognized pathway for the repair of rU-specific ribonucleotides. Additionally, we developed a method for selectively quantifying rU content in DNA. Using this method, we determined that rU repair by UDG is not a major pathway in human cells. This discovery expands our understanding of the diverse biological functions of UDG, and inspires further investigation to determine the role of its rU-removal in cells.


  • Inhibitors of SAMHD1 Obtained from Chemical Tethering to the Guanine Antiviral Acyclovir

    by Matthew Egleston, Shridhar Bhat, A. Hasan Howlader, Mario A. Bianchet, Yi Liu, Laura Maria Lopez Rovira, Brandon Smith, Marc M. Greenberg, James T. Stivers

    Sterile alpha motif histidine-aspartate domain protein 1 (SAMHD1) is an enzyme with diverse activities. Its dNTPase activity degrades all canonical dNTPs and many anticancer nucleoside drugs, while its single-stranded nucleic acid binding activity promotes DNA repair and RNA homeostasis in cells. These functions require guanine nucleotide binding to a specific allosteric site (A1) on the enzyme. We previously described how the activities of SAMHD1 could be inhibited in vitro with fragment-based inhibitor design, using dGMP as a targeting fragment for the A1 site. However, these dGMP-tethered inhibitors had poor cell permeability due to the charged guanine monophosphate group. Here, we describe a new approach where the amino form of the guanine acyclic nucleoside acyclovir (NH2-ACV) is used as the targeting fragment, allowing facile coupling to activated carboxylic acids (R-COOH), either directly or using linkers. This approach generates a neutral amide instead of charged monophosphate attachment points. High-throughput screening of a ∼375 compound carboxylic acid library identified two compounds (8, 11) with similar micromolar affinities for SAMHD1. Compound 11 was obtained by direct coupling to NH2-ACV, while compound 8 used a five-carbon linker. Both inhibitors had the same dibromonaphthol component from the carboxylic acid library screen. A crystal structure of a complex between SAMHD1 and 8, combined with computational models of bound 11, suggest how the dibromonaphthol promotes binding. The findings establish that guanine-based inhibitors targeting the A1 site do not require nucleotide or cyclic nucleoside structural elements. This guanine site targeting strategy is highly amenable to further chemical optimization.